Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol-Reference-Cited by-同舟云学术

Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol

Published:2023-05 Issue: Volume:40 Page:100613
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Rogé Maximilien^ORCID,Pointreau Yoann,Sargos Paul,Meyer Emmanuel,Schick Ulrike,Hasbini Ali,Rio Emmanuel,Bera Guillaume^ORCID,Ruffier Amandine,Quivrin Magali,Chasseray Mathieu,Latorzeff Igor^ORCID,Martin Etienne,Guimas Valentine,Pommier Pascal,Leroy Thomas,Ronchin Philippe,Lepinoy Alexis,Grand Audrey,Cartier Lysian,Didas Ossama,Denis Fabrice,Libois Vincent,Blanc-Lapierre Audrey,Supiot Stéphane

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference22 articles.

1. Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options;Moreno;Radiat Oncol,2014

2. Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy;Schweizer;Ann Oncol,2013

3. Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer: Oligometastatic Prostate Cancer;Ost;Prostate,2014

4. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial;Phillips;JAMA Oncol,2020

5. Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial;Ost;J Clin Oncol,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five‐year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial;International Journal of Cancer;2024-06-19

2. Review of Current Treatment Intensification Strategies for Prostate Cancer Patients;Cancers;2023-11-28

3. Highly multiplexed immune profiling throughout adulthood reveals kinetics of lymphocyte infiltration in the aging mouse prostate;Aging;2023-05-13